CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,032,584
- in 16 filings, $9.5M under 10b5-1 plans
Net −$17,032,584. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-28 | Schundler Russell General Counsel | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,343 | 2,344 | ||
| 2025-11-28 | Kaseta Michael CFO and COO | Exercise or conversion 10b5-1 | +2,343 | 354,989 | ||
| 2025-11-28 | Kaseta Michael CFO and COO | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,343 | 2,344 | ||
| 2025-11-28 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +1,563 | 176,561 | ||
| 2025-11-28 | Adair Jason Chief Business Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,563 | 1,562 | ||
| 2025-11-28 | Moomaw Scott Chief Commercial Officer | Exercise or conversion 10b5-1 | +1,875 | 155,337 | ||
| 2025-11-28 | Moomaw Scott Chief Commercial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,875 | 1,875 | ||
| 2025-11-18 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +35,291 | $5.89 | $208K | 210,289 |
| 2025-11-18 | Adair Jason Chief Business Officer | Exercise or conversion 10b5-1 | +365 | $5.89 | $2K | 210,654 |
| 2025-11-18 | Adair Jason Chief Business Officer | Sale 10b5-1 | −35,656 | $30.03 | $1.1M | 174,998 |
| 2025-11-18 | Adair Jason Chief Business Officer | Exercise or conversion · Incentive Stock Option (right to buy) 10b5-1 | −35,291 | 0 | ||
| 2025-11-18 | Adair Jason Chief Business Officer | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −365 | 0 | ||
| 2025-11-07 | Boyle Dana Chief Accounting Officer | Sale | −8,342 | $25.16 | $210K | 175,996 |
| 2025-11-07 | Boyle Dana Chief Accounting Officer | Sale | −20,662 | $25.06 | $518K | 155,334 |
| 2025-11-05 | Saggar Rajeev Chief Medical Officer | Sale | −4,918 | $27.00 | $133K | 243,012 |
| 2025-11-05 | Saggar Rajeev Chief Medical Officer | Sale | −66,463 | $27.00 | $1.8M | 176,549 |
| 2025-10-27 | Adair Jason Chief Business Officer | Sale 10b5-1 | −692 | $22.93 | $16K | 174,998 |
| 2025-10-27 | Boyle Dana Chief Accounting Officer | Sale 10b5-1 | −1,073 | $22.93 | $25K | 184,338 |
| 2025-10-13 | Schundler Russell General Counsel | Sale 10b5-1 | −7,839 | $23.41 | $184K | 576,017 |
| 2025-10-13 | Kaseta Michael CFO and COO | Sale 10b5-1 | −11,630 | $23.41 | $272K | 352,646 |
Page 20 of 29 · 579 trades